Vaccines are the biological preparation used for stimulating antibody production to activate immune system against diseases such as influenza, Hepatitis A, Hepatitis B, Human Papillomavirus, Polio, and Rabies. High prevalence of infectious disease and increasing governmental initiative for implementing nationalized vaccination programme are expected to drive growth of the vaccine market, whereas high developmental cost of vaccine is expected to hamper growth of the vaccine market. For instance, according to the Centers for Disease Control and Prevention (CDC), 2015, flu vaccinations prevented an around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden in the U.S.
Market Dynamics
The global disease control and prevention vaccine market is projected to witness significant growth over the forecast period, owing to rapid advancements in technology for development of novel vaccines such as recombinant and cell-based technologies, resulting in increasing production of the vaccines. For instance, in 2018, collaboration between Austrian biotech Themis Bioscience and Oslo-based Coalition for Epidemic Preparedness Innovations (CEIP). CEIP will fund US$ 37.5 million for vaccine development for five years. Moreover, governmental bodied supports the research and development program leading to the development of improved form of presently available vaccines. For instance, in 2015, a National Institute of Allergy and Infectious Disease scientists engineered a protein to maintain the specific shape of the viral spike, stimulating the immune system to produce powerful anti-HIV antibodies. However, manufacturing cost as well as large gap between demand and supply leading to hike in pricing is expected to hinder the growth of disease control and prevention vaccination market.
Key features of the study:
- This report provides in-depth analysis of the disease control and prevention vaccine market and its Type, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2017 – 2025, considering 2016 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global disease control and prevention vaccine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
- Key companies covered as a part of this study include GlaxoSmithKline plc (GSK), Merck & Co. Inc., Sanofi, AstraZeneca PLC, Pfizer, Inc., Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., Astellas Pharma Inc., and Daiichi Sankyo
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion and marketing tactics.
- The global disease control and prevention vaccine market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for disease control and prevention vaccine market, research and consulting firms, new entrants and financial analysts.
Detailed Segmentation:
- Global Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Global Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Global Disease Control and Prevention Vaccine Market, By Route of Administration:
- Global Disease Control and Prevention Vaccine Market, By Age Group:
- Global Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Global Disease Control and Prevention Vaccine Market, By Region:
- North America
- U.S.
- U.S. Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- U.S. Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- U.S. Disease Control and Prevention Vaccine Market, By Route of Administration:
- U.S. Disease Control and Prevention Vaccine Market, By Age Group:
- U.S. Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Canada
- Canada Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Canada Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Canada Disease Control and Prevention Vaccine Market, By Route of Administration:
- Canada Disease Control and Prevention Vaccine Market, By Age Group:
- Canada Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Europe
- U.K.
- U.K. Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- U.K. Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- U.K. Disease Control and Prevention Vaccine Market, By Route of Administration:
- U.K. Disease Control and Prevention Vaccine Market, By Age Group:
- U.K. Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Germany
- Germany Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Germany Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Germany Disease Control and Prevention Vaccine Market, By Route of Administration:
- Germany Disease Control and Prevention Vaccine Market, By Age Group:
- Germany Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Italy
- Italy Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Italy Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Italy Disease Control and Prevention Vaccine Market, By Route of Administration:
- Italy Disease Control and Prevention Vaccine Market, By Age Group:
- Italy Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- France
- France Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- France Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- France Disease Control and Prevention Vaccine Market, By Route of Administration:
- France Disease Control and Prevention Vaccine Market, By Age Group:
- France Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Spain
- Spain Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Spain Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Spain Disease Control and Prevention Vaccine Market, By Route of Administration:
- Spain Disease Control and Prevention Vaccine Market, By Age Group:
- Spain Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Russia
- Russia Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Russia Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Russia Disease Control and Prevention Vaccine Market, By Route of Administration:
- Russia Disease Control and Prevention Vaccine Market, By Age Group:
- Russia Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Rest of Europe
- Rest of Europe Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Rest of Europe Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Rest of Europe Disease Control and Prevention Vaccine Market, By Route of Administration:
- Rest of Europe Disease Control and Prevention Vaccine Market, By Age Group:
- Rest of Europe Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Asia-Pacific
- China
- China Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- China Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- China Disease Control and Prevention Vaccine Market, By Route of Administration:
- China Disease Control and Prevention Vaccine Market, By Age Group:
- China Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- India
- India Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- India Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- India Disease Control and Prevention Vaccine Market, By Route of Administration:
- India Disease Control and Prevention Vaccine Market, By Age Group:
- India Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Japan
- Japan Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Japan Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Japan Disease Control and Prevention Vaccine Market, By Route of Administration:
- Japan Disease Control and Prevention Vaccine Market, By Age Group:
- Japan Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- ASEAN
- ASEAN Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- ASEAN Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- ASEAN Disease Control and Prevention Vaccine Market, By Route of Administration:
- ASEAN Disease Control and Prevention Vaccine Market, By Age Group:
- ASEAN Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Australia
- Australia Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Australia Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Australia Disease Control and Prevention Vaccine Market, By Route of Administration:
- Australia Disease Control and Prevention Vaccine Market, By Age Group:
- Australia Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- South Korea
- South Korea Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- South Korea Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- South Korea Disease Control and Prevention Vaccine Market, By Route of Administration:
- South Korea Disease Control and Prevention Vaccine Market, By Age Group:
- South Korea Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Rest of Asia Pacific
- Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Route of Administration:
- Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Age Group:
- Rest of Asia Pacific Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Latin America
- Brazil
- Brazil Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Brazil Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Brazil Disease Control and Prevention Vaccine Market, By Route of Administration:
- Brazil Disease Control and Prevention Vaccine Market, By Age Group:
- Brazil Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Mexico
- Mexico Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Mexico Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Mexico Disease Control and Prevention Vaccine Market, By Route of Administration:
- Mexico Disease Control and Prevention Vaccine Market, By Age Group:
- Mexico Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Rest of Latin America
- Rest of Latin America Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Rest of Latin America Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Rest of Latin America Disease Control and Prevention Vaccine Market, By Route of Administration:
- Rest of Latin America Disease Control and Prevention Vaccine Market, By Age Group:
- Rest of Latin America Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Middle East
- GCC
- GCC Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- GCC Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- GCC Disease Control and Prevention Vaccine Market, By Route of Administration:
- GCC Disease Control and Prevention Vaccine Market, By Age Group:
- GCC Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Israel
- Israel Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Israel Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Israel Disease Control and Prevention Vaccine Market, By Route of Administration:
- Israel Disease Control and Prevention Vaccine Market, By Age Group:
- Israel Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Rest of Middle East
- Rest of Middle East Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Rest of Middle East Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Rest of Middle East Disease Control and Prevention Vaccine Market, By Route of Administration:
- Rest of Middle East Disease Control and Prevention Vaccine Market, By Age Group:
- Rest of Middle East Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Africa
- North Africa
- North Africa Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- North Africa Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- North Africa Disease Control and Prevention Vaccine Market, By Route of Administration:
- North Africa Disease Control and Prevention Vaccine Market, By Age Group:
- North Africa Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Central Africa
- Central Africa Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- Central Africa Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- Central Africa Disease Control and Prevention Vaccine Market, By Route of Administration:
- Central Africa Disease Control and Prevention Vaccine Market, By Age Group:
- Central Africa Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- South Africa
- South Africa Disease Control and Prevention Vaccine Market, By Product Type:
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- South Africa Disease Control and Prevention Vaccine Market, By Type:
- Monovalent Vaccine
- Multivalent Vaccine
- South Africa Disease Control and Prevention Vaccine Market, By Route of Administration:
- South Africa Disease Control and Prevention Vaccine Market, By Age Group:
- South Africa Disease Control and Prevention Vaccine Market, By Indication:
- Infectious Disease
- Cancer
- Other Indication
- Company Profiles
- GlaxoSmithKline plc (GSK) *
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Merck & Co. Inc.
- Sanofi
- AstraZeneca PLC
- Pfizer, Inc.
- Serum Institute of India Pvt. Ltd.
- Sinovac Biotech Ltd.
- Astellas Pharma Inc.
- Daiichi Sankyo
“*” marked represents similar segmentation in other categories in the respective section.
